Dupont Capital Management Corp Buys 933 Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN

published 27.07.2020 11:20

Dupont Capital Management Corp lifted its holdings in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 24.0% in the second quarter, Holdings Channel.com reports.

Parkside Financial Bank & Trust raised its holdings in shares of Regeneron Pharmaceuticals by 44.2% during the first quarter.

Parkside Financial Bank & Trust now owns 62 shares of the biopharmaceutical company’s stock valued at $30,000 after acquiring an additional 19 shares in the last quarter.

Endurance Wealth Management Inc. now owns 50 shares of the biopharmaceutical company’s stock valued at $31,000 after acquiring an additional 18 shares in the last quarter.

Wells Fargo & Co upgraded Regeneron Pharmaceuticals from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $559.00 to $734.00 in a report on Tuesday, May 26th.

by James Nelson from dispatchtribunal.com

Free awesomeness straight to your inbox!

Sign up now for this free newsletter to receive hand picked content, covering topics like Lifestyle, Business & Technology.

Free Newsletter Sign up now!

..or jump directly to the latest posts!